Carbamoylcholine, also known as carbachol, is a muscarinic agonist discovered in 1932.[A226315] Carbamoylcholine was initially used as a treatment for migraines,[A226365] induction of diuresis,[A226370] and other parasympathetic effects. Carbamoylcholine was granted FDA approval on 28 September 1972.[L30245]
Synonyms
Carbamoylcholine
Choline carbamate
Carbamoylcholine chloride
Carbacholine
Carbamylcholine
carbacol
Brand Names
Isopto Carbachol 3%
Miostat
Carbachol Injection Liq Sc 0.25mg/ml
Carbachol Intraocular Solution 0.01%
Carbachol Tab 2mg
Miostat Ophthalmic Liq 0.01%
Carbastat
Isopto Carbachol 1.5%
Carbachol
Isopto Carbachol
Indication
Carbamoylcholine is indicated to induce miosis for surgery and to reduce intraocular pressure elevations in the first 24 hours after cataract surgery.[L30245]
Categories
Alcohols
Amines
Amino Alcohols
Ammonium Compounds
Analgesics
Analgesics, Non-Narcotic
Antiglaucoma Preparations and Miotics
Autonomic Agents
Cardiotonic Agents
Cardiovascular Agents
Central Nervous System Agents
Choline Esters
Cholinergic Agents
Cholinergic Agonists
Cholinergic Receptor Agonist
Compounds used in a research, industrial, or household setting
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682